Juniper Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JNP and buy or sell other stocks, options, and ETFs commission-free!About JNP
Juniper Pharmaceuticals (Nasdaq: JNP) is developing therapeutics that address unmet medical needs in women’s health. Their current pipeline leverages the 505(b)(2) regulatory pathway with new formulations of existing pharmaceuticals.
CEOJohn R. Chiminski
CEOJohn R. Chiminski
Employees—
Employees—
HeadquartersSomerset, New Jersey
HeadquartersSomerset, New Jersey
Founded1986
Founded1986
Employees—
Employees—
JNP Key Statistics
Market cap127.71M
Market cap127.71M
Price-Earnings ratio-115.00
Price-Earnings ratio-115.00
Dividend yield—
Dividend yield—
Average volume81.86K
Average volume81.86K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.25
52 Week high$13.25
52 Week low$4.30
52 Week low$4.30